Dopamine Agonists (administration & dosage) < Dopamine Agonists (adverse effects) < Dopamine Agonists (blood)

Facettes :

List of bibliographic references indexed by Dopamine Agonists (adverse effects)

Number of relevant bibliographic references: 84.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000821 (2013)	Jesse Bastiaens [États-Unis] ; Benjamin J. Dorfman [États-Unis] ; Paul J. Christos [États-Unis] ; Melissa J. Nirenberg [États-Unis]	Prospective Cohort Study of Impulse Control Disorders in Parkinson’s Disease
000A78 (2013)	David J. Graham [États-Unis] ; James R. Williams ; Ya-Hui Hsueh ; Katlyn Calia ; Mark Levenson ; Simone P. Pinheiro ; Thomas E. Macurdy ; David Shih ; Chris Worrall ; Jeffrey A. Kelman	Cardiovascular and mortality risks in Parkinson's disease patients treated with entacapone.
000C78 (2012)	Ainhi D. Ha [États-Unis] ; Joseph Jankovic [États-Unis]	Pain in Parkinson's disease.
001157 (2012)	Donald L. Bliwise [États-Unis] ; Lynn Marie Trotti [États-Unis] ; Anthony G. Wilson [États-Unis] ; Sophia A. Greer [États-Unis] ; Cathy Wood-Siverio [États-Unis] ; Jorge J. Juncos [États-Unis] ; Stewart A. Factor [États-Unis] ; Alan Freeman [États-Unis] ; David B. Rye [États-Unis]	Daytime Alertness in Parkinson's Disease: Potentially Dose-Dependent, Divergent Effects by Drug Class
001244 (2011)	Vibeke Guldbrand Rasmussen [Danemark] ; Karen Stergaard ; Erik Dupont ; Steen Hvitfeldt Poulsen	The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists.
001355 (2011)	Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Ad Theeuwes [Pays-Bas] ; Fabrizio Stocchi [Italie] ; Joaquim J. Ferreira [Portugal] ; Serge Van De Witte [Pays-Bas] ; Juliana Bronzova [Pays-Bas]	Temporal stability of the Unified Dyskinesia Rating Scale
001474 (2011)	Atbin Djamshidian [Royaume-Uni] ; Francisco Cardoso [Brésil] ; Donald Grosset [Royaume-Uni] ; Henrietta Bowden-Jones [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Pathological gambling in Parkinson's disease—a review of the literature
001773 (2011)	Louis C. S. Tan [Singapour] ; Kenneth K. C. Ng [Singapour] ; Wing-Lok Au [Singapour] ; Raymond K. K. Lee [Singapour] ; Nigel C. K. Tan [Singapour]	Bromocriptine use and myocardial function
001937 (2010)	Stephen Gancher [États-Unis] ; John Nutt [États-Unis]	Tolerance to apomorphine develops and reverses rapidly
001A61 (2010)	Sean S. O'Sullivan [Royaume-Uni] ; Andrew H. Evans [Australie] ; Niall P. Quinn [Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	Reckless generosity in Parkinson's disease
001B51 (2010)	Melissa J. Nirenberg [États-Unis] ; Cheryl Waters [États-Unis]	Nocturnal eating in restless legs syndrome
001C03 (2010)	Fanny Pineau [France] ; Michael Schüpbach [France] ; Jean-Christophe Corvol [France] ; Constance Flamand-Rouvière [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France]	Long‐standing paraphilia induced by dopamine agonists in Parkinson's disease
001C55 (2010)	Mario Coletti Moja [Italie]	Hiccups associated with non‐ergoline dopamine agonists in Parkinson's disease
001D73 (2010)	Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni]	Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward
001E61 (2010)	Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
002001 (2009)	Leon Poltawski [Royaume-Uni] ; Hazel Edwards [Royaume-Uni] ; Amy Todd [Royaume-Uni] ; Tim Watson [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Cherry Ann James [Royaume-Uni]	Ultrasound treatment of cutaneous side‐effects of infused apomorphine: A randomized controlled pilot study
002086 (2009)	Silva Link [Allemagne] ; Walter Paulus [Allemagne] ; Borwin Bandelow [Allemagne]	Remission of acute psychotic anxious depression in a patient with Parkinson's disease after treatment with quetiapine
002107 (2009)	Andrew H. Evans [Australie] ; James R. Stegeman [Australie]	Punding in patients on dopamine agonists for restless leg syndrome
002257 (2009)	Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis]	Impulsive and compulsive behaviors in Parkinson's disease
002347 (2009)	Esther M. Sammler [Royaume-Uni] ; Robert J. Swingler [Royaume-Uni] ; Arlene Stuart [Royaume-Uni] ; Miratul Muqit [Royaume-Uni]	Dopamine dysregulation syndrome in a patient with early onset Parkinsonism and Parkin gene mutations
002348 (2009)	Akiyuki Uzawa [Japon] ; Masahiro Mori [Japon] ; Shigeyuki Kojima [Japon] ; Satsuki Mitsuma [Japon] ; Yukari Sekiguchi [Japon] ; Toshihide Kanesaka [Japon] ; Satoshi Kuwabara [Japon]	Dopamine agonist‐induced antecollis in Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine Agonists (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine Agonists (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agonists (adverse effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024